964.3 BC MSP code: Poisoning by agents primarily affecting blood constituents – Vitamin K (phytomenadione)
964.3 is the BC MSP diagnostic code for “Poisoning by agents primarily affecting blood constituents – Vitamin K (phytomenadione)” in BC Medical Services Plan’s September 2026 release, in effect from Sep 11, 2026.
Official description
964.3Poisoning by agents primarily affecting blood constituents – Vitamin K (phytomenadione)
BC MSP diagnostic codes (ICD-9) · British Columbia
Notes for 964.3
BC Medical Services Plan’s list gives no includes, excludes or other notes for 964.3 or the headings above it.
Where 964.3 sits
- 1Valid code 964Poisoning by agents primarily affecting blood constituents
- 2Valid code 964.3Poisoning by agents primarily affecting blood constituents – Vitamin K (phytomenadione)
Source and release
- Data release
- BC MSP · September 2026
- Effective date
- Sep 11, 2026
- Publisher
- BC Medical Services Plan
This page is built from the BC MSP catalog that Vero Codes reads when it suggests codes: BC Ministry of Health, Medical Services Plan’s September 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does BC MSP diagnostic code 964.3 mean?
964.3 is the BC MSP diagnostic code for “Poisoning by agents primarily affecting blood constituents – Vitamin K (phytomenadione)” in BC Medical Services Plan’s BC MSP September 2026 release.
Where is 964.3 in BC MSP?
964.3 sits under 964 Poisoning by agents primarily affecting blood constituents.
What coding notes apply to 964.3?
BC Medical Services Plan’s list gives no includes, excludes or other notes for 964.3 or the headings above it.
Which BC MSP release does this page use?
It uses BC Medical Services Plan’s September 2026 release, in effect from Sep 11, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside 964.3
View 964964.0Poisoning by agents primarily affecting blood constituents – Iron and its compounds964.1Poisoning by agents primarily affecting blood constituents – Liver preparations and other antianaemic agents964.2Poisoning by agents primarily affecting blood constituents – Anticoagulants964.4Poisoning by agents primarily affecting blood constituents – Fibrinolysis-affecting drugs964.5Poisoning by agents primarily affecting blood constituents – Anticoagulant antagonists and other coagulants964.6Poisoning by agents primarily affecting blood constituents – Gamma globulin964.7Poisoning by agents primarily affecting blood constituents – Natural blood and blood products964.8Poisoning by agents primarily affecting blood constituents – Other964.9Poisoning by agents primarily affecting blood constituents – Unspecified